Namiki Izumi

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Journal of gastroenterology and hepatology

PloS one

Hepatology international

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Hidekatsu Kuroda, Takuma Oguri, Naohisa Kamiyama, Hidenori Toyoda, Satoshi Yasuda, Kento Imajo, Yasuaki Suzuki, Katsutoshi Sugimoto, Tomoyuki Akita, Junko Tanaka, Yutaka Yasui, Masayuki Kurosaki, Namiki Izumi, Hirokazu Takahashi, Yudai Fujiwara, Tamami Abe, Keisuke Kakisaka, Takayuki Matsumoto, Takashi Kumada
Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis. Radiology 309 (1) (2023)
Shun Kaneko, Masayuki Kurosaki, Kaoru Tsuchiya, Yutaka Yasui, Yuka Hayakawa, Kento Inada, Yuki Tanaka, Shun Ishido, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Hiroyuki Nakanishi, Namiki Izumi
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma. PloS one 17 (3) (2022)
Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Mayu Higuchi, Kenta Takaura, Shun Kaneko, Chiaki Maeyashiki, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Namiki Izumi
Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease. Journal of gastroenterology and hepatology 37 (9) (2022)
Shun Kaneko, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Yuka Hayakawa, Koji Yamashita, Leona Osawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Jun Itakura, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Namiki Izumi
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients. Journal of gastroenterology and hepatology 36 (10) (2021)
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Namiki Izumi
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. Journal of gastroenterology and hepatology 36 (10) (2021)
Shun Kaneko, Masayuki Kurosaki, Toru Sugiyama, Yuka Takahashi, Yoshimi Yamaguchi, Masayuki Nagasawa, Namiki Izumi
The dynamics of quantitative SARS-CoV-2 antispike IgG response to BNT162b2 vaccination. Journal of medical virology 93 (12) (2021)
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Kaoru Tsuchiya, Namiki Izumi
Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease. Journal of medical ultrasonics (2001) 48 (4) (2021)
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Koji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Rohit Loomba, Namiki Izumi
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (9) (2021)
Nobuharu Tamaki, Masayuki Kurosaki, Stephen Caldwell, Namiki Izumi
Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases. Annals of laboratory medicine 41 (1) (2020)
Sakura Kirino, Nobuharu Tamaki, Shun Kaneko, Masayuki Kurosaki, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Keiya Watakabe, Mao Okada, Wan Wang, Takao Shimizu, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Yutaka Yasui, Hiroyuki Nakanishi, Kaoru Tsuchiya, Jun Itakura, Yuka Takahashi, Namiki Izumi
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog. Journal of gastroenterology and hepatology 35 (9) (2020)
Sakura Kirino, Kaoru Tsuchiya, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mao Okada, Wan Wang, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Namiki Izumi
Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma. PloS one 15 (4) (2020)
Shun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Takaya Takeguchi, Yuko Takeguchi, Takuya Nagano, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yoshiro Himeno, Akihiko Hoshi, Masayuki Kurosaki, Namiki Izumi
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis. Hepatology research : the official journal of the Japan Society of Hepatology 50 (12) (2020)
Hitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, Yuka Takahashi, Jun Itakura, Kaoru Tsuchiya, Yutaka Yasui, Nobuharu Tamaki, Kenta Takaura, Yasuyuki Komiyama, Mayu Higuchi, Youhei Kubota, Wann Wang, Mao Okada, Takao Shimizu, Keiya Watakabe, Nobuyuki Enomoto, Namiki Izumi
Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures. PloS one 14 (2) (2019)
Namiki Izumi, Tetsuo Takehara, Kazuaki Chayama, Hiroshi Yatsuhashi, Koichi Takaguchi, Tatsuya Ide, Masayuki Kurosaki, Yoshiyuki Ueno, Hidenori Toyoda, Satoru Kakizaki, Yasuhito Tanaka, Yoshiiku Kawakami, Hirayuki Enomoto, Fusao Ikeda, Deyuan Jiang, Shampa De-Oertel, Brian L McNabb, Gregory Camus, Luisa M Stamm, Diana M Brainard, John G McHutchison, Satoshi Mochida, Masashi Mizokami
Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals. Hepatology international 12 (4) (2018)

Namiki Izumi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Namiki Izumi